Latest Hypopnea Stories
BOSTON, Dec. 12, 2014 /PRNewswire/ -- On Friday, December 12, 2014 Human Design Medical, LLC (HDM) announced its Z1 Auto(TM) CPAP, which makes a quantum leap forward in CPAP therapy.
ACP’s new evidence-based guideline recommends sleep study for individuals with unexplained daytime sleepiness.
Continuous positive airway pressure (CPAP), the most widely prescribed therapy for treatment of obstructive sleep apnea, resulted in significantly lower blood pressure compared to either nocturnal supplemental oxygen or an educational control treatment.
A new study with more than 8,500 Canadian patients revealed a link between obstructive sleep apnea (OSA) and the onset of diabetes. The study was the largest one of its kind to date and the results confirmed what earlier studies revealed with smaller and shorter follow-up periods.
Clinically important sleep apnea is common among survivors of acute respiratory failure.
Dental Sleep Medicine education company, Sleep Group Solutions, provide Dental education on implementing a sleep protocol, via two day programs involving Sleep Apnea signs and symptoms, including
SAN DIEGO, March 14, 2014 /PRNewswire/ -- To coincide with today's World Sleep Day, ResMed (NYSE: RMD), an innovator and pioneer in developing solutions for treating sleep-disordered breathing
THE REMEDE SYSTEM RECOGNIZED AS 2014 BEST INNOVATION AT CRT CONFERENCE MINNEAPOLIS, March 12, 2014 /PRNewswire/ -- Respicardia(®), Inc., a developer of implantable therapies to improve
Dr. Shreedevi Thulasidas DDS, BDS, FAGD, MS (Dr. Devi) of Smile Design Specialists is now helping patients who suffer from sleep apnea. Dr.
Obstructive sleep apnea (OSA) generally is associated with increased risk for cardiovascular (CV) disease.